Cargando…

Non-alcoholic fatty liver disease may develop in individuals with normal body mass index

BACKGROUND: Although non-alcoholic fatty liver disease (NAFLD) is associated with obesity and metabolic syndrome (MS), it may also be present in lean individuals. We evaluated the characteristics of NAFLD patients, focusing on those with normal body mass index (BMI). METHODS: One hundred and sixty-t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Margariti, Ekaterini, Deutsch, Melanie, Manolakopoulos, Spilios, Papatheodoridis, George V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hellenic Society of Gastroenterology 2012
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3959339/ https://www.ncbi.nlm.nih.gov/pubmed/24713801

Ejemplares similares

Serum zonulin levels in patients with liver cirrhosis: Prognostic implications
por: Voulgaris, Theodoros A, et al.
Publicado: (2021)

Serum levels of vascular endothelial growth factor in non-alcoholic fatty liver disease
por: Papageorgiou, Maria-Vasiliki, et al.
Publicado: (2017)

Hepatitis B and C coinfection in a real-life setting: viral interactions and treatment issues
por: Papadopoulos, Nikolaos, et al.
Publicado: (2018)

The Impact of Host Metabolic Factors on Treatment Outcome in Chronic Hepatitis C
por: Savvoula, Savvidou, et al.
Publicado: (2012)

Bacterial infections in patients with liver cirrhosis: clinical characteristics and the role of C-reactive protein
por: Deutsch, Melanie, et al.
Publicado: (2018)

Clinicopathological characteristics and metabolic profiles of non-alcoholic fatty liver disease in Indian patients with normal body mass index: Do they differ from obese or overweight non-alcoholic fatty liver disease?
por: Kumar, Ramesh, et al.
Publicado: (2013)

Significance of the (13)C-caffeine breath test for patients with cirrhosis
por: Konstantinou, Dimitrios, et al.
Publicado: (2014)

Elastography for Hepatic Fibrosis Severity in Chronic Hepatitis B or C
por: Papageorgiou, Maria-Vasiliki, et al.
Publicado: (2011)

Correlation of Body Mass Index and Serum Parameters With Ultrasonographic Grade of Fatty Change in Non-alcoholic Fatty Liver Disease
por: Abangah, Ghobad, et al.
Publicado: (2014)

Body mass index related electrocardiographic findings in healthy young individuals with a normal body mass index
por: Hassing, G. J., et al.
Publicado: (2019)

Liver fibrosis staging with combination of APRI and FIB-4 scoring systems in chronic hepatitis C as an alternative to transient elastography
por: Papadopoulos, Nikolaos, et al.
Publicado: (2019)

Muscle strength, but not body mass index, is associated with mortality in patients with non‐alcoholic fatty liver disease
por: Charatcharoenwitthaya, Phunchai, et al.
Publicado: (2022)

Determining whether the effect of liraglutide on non‐alcoholic fatty liver disease depends on reductions in the body mass index
por: Shiomi, Megumi, et al.
Publicado: (2020)

Novel multi-parametric diagnosis of non-alcoholic fatty liver disease using ultrasonography, body mass index, and Fib-4 index
por: Funada, Kei, et al.
Publicado: (2023)

The Relation of Body Mass Index to Muscular Viscoelastic Properties in Normal and Overweight Individuals
por: Usgu, Serkan, et al.
Publicado: (2021)

Direct-acting antiviral treatment for chronic hepatitis C in people who use drugs in a real-world setting
por: Koustenis, Kanellos Rafail, et al.
Publicado: (2020)

Outcome after discontinuation of nucleot(s)ide analogues in chronic hepatitis B: relapse rate and associated factors
por: Kranidioti, Hariklia, et al.
Publicado: (2015)

Value of the triglyceride glucose index combined with body mass index in identifying non-alcoholic fatty liver disease in patients with type 2 diabetes
por: Li, Nong, et al.
Publicado: (2022)

The triglyceride glucose-body mass index: a non-invasive index that identifies non-alcoholic fatty liver disease in the general Japanese population
por: Hu, Haofei, et al.
Publicado: (2022)

Clinical and epidemiological characteristics of hepatitis C virus-infected people who inject drugs: a Greek descriptive analysis
por: Kranidioti, Hariklia, et al.
Publicado: (2018)

Aspartate aminotransferase-platelet ratio index, adiponectin and body mass index in children with fatty liver
por: Kusumawati, Ninung RD, et al.
Publicado: (2013)

Aiming towards hepatitis C virus elimination in Greece
por: Papatheodoridis, George V., et al.
Publicado: (2019)

Association of maternal diabetes/glycosuria and pre-pregnancy body mass index with offspring indicators of non-alcoholic fatty liver disease
por: Patel, Sumaiya, et al.
Publicado: (2016)

Application value of triglyceride-glucose index and triglyceride-glucose body mass index in evaluating the degree of hepatic steatosis in non-alcoholic fatty liver disease
por: Wang, Mengyuan, et al.
Publicado: (2023)

Significance of Circulating Cell-Free DNA Species in Non-Alcoholic Fatty Liver Disease
por: Chrysavgis, Lampros, et al.
Publicado: (2021)

Safety and efficacy of daclatasvir in the management of patients with chronic hepatitis C
por: Manolakopoulos, Spilios, et al.
Publicado: (2016)

Role of band ligation for secondary prophylaxis of variceal bleeding
por: Aggeletopoulou, Ioanna, et al.
Publicado: (2018)

Risk of hepatitis B reactivation in patients treated with direct-acting antivirals for hepatitis C
por: Aggeletopoulou, Ioanna, et al.
Publicado: (2017)

The value of combining the simple anthropometric obesity parameters, Body Mass Index (BMI) and a Body Shape Index (ABSI), to assess the risk of non-alcoholic fatty liver disease
por: Kuang, Maobin, et al.
Publicado: (2022)

Clinical and Laboratory Characteristics of Normal Weight and Obese Individuals with Non-Alcoholic Fatty Liver Disease
por: Trifan, Anca, et al.
Publicado: (2022)

Correlation of gut Firmicutes/Bacteroidetes ratio with fibrosis and steatosis stratified by body mass index in patients with non-alcoholic fatty liver disease
por: JASIRWAN, Chyntia Olivia Maurine, et al.
Publicado: (2020)

Fat mass index as a screening tool for the assessment of non-alcoholic fatty liver disease
por: Zhang, Shengkui, et al.
Publicado: (2022)

Non-alcoholic fatty liver disease and cerebral small vessel disease in Korean cognitively normal individuals
por: Jang, Hyemin, et al.
Publicado: (2019)

Associations between neck circumference and markers of dysglycemia, non-alcoholic fatty liver disease, and dysmetabolism independent of Body Mass Index in an Emirati population
por: Fojas, Esphie Grace Fodra, et al.
Publicado: (2022)

Monitoring and comorbidities in patients with chronic hepatitis B currently treated with nucleos(t)ide analogs
por: Siakavellas, Spyros, et al.
Publicado: (2021)

Nonalcoholic fatty liver disease is associated with dysbiosis independent of body mass index and insulin resistance
por: Da Silva, Hannah E., et al.
Publicado: (2018)

Association between body mass index and fatty liver risk: A dose-response analysis
por: Fan, Rui, et al.
Publicado: (2018)

Effect of physical activity on the development and the resolution of nonalcoholic fatty liver in relation to body mass index
por: Choi, Hyo-In, et al.
Publicado: (2022)

Non-alcoholic fatty liver disease in lean individuals
por: Albhaisi, Somaya, et al.
Publicado: (2019)

Association between body roundness index and non‐alcoholic fatty liver disease detected by Fibroscan in America
por: Jiang, Ningning, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_o44dfi8vv52tnheit2rpc0b10g